Platelet vesicles help cardiac stem cells engraft

[1]  J. Ferrières,et al.  Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015 , 2017, Circulation.

[2]  Bernd Hertenstein,et al.  Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial , 2017, European heart journal.

[3]  R. Bolli,et al.  Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction , 2017, Basic Research in Cardiology.

[4]  A. Mathur,et al.  Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews , 2016, Clinical pharmacology and therapeutics.

[5]  A. Arai,et al.  Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium. , 2016, Cardiovascular revascularization medicine : including molecular interventions.

[6]  Doris A Taylor,et al.  Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials , 2016, Basic Research in Cardiology.

[7]  J. Olgin,et al.  Immuno-modification of enhancing stem cells targeting for myocardial repair , 2015, Journal of cellular and molecular medicine.

[8]  V. Jain,et al.  Nanomedicines based drug delivery systems for anti-cancer targeting and treatment. , 2015, Current drug delivery.

[9]  Matt Trau,et al.  Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing , 2015, Scientific Reports.

[10]  Tianfu Wang,et al.  The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. , 2014, Biomaterials.

[11]  Daniel Berman,et al.  Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.

[12]  M. Penn,et al.  Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell , 2012, Journal of drug targeting.

[13]  A. Ganser,et al.  Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium , 2005, Circulation.

[14]  Ashley C. Brown,et al.  Targeted repair of heart injury by stem cells fused with platelet nanovesicles , 2017, Nature Biomedical Engineering.